MyFinsight
Home
Blog
About
Cash and cash
equivalents
$5,016K
(-61.65%↓ Y/Y)
Tax incentive and
other receivables
$3,454K
(161.07%↑ Y/Y)
Prepaid expenses and
other assets
$553K
(-42.75%↓ Y/Y)
Total current assets
$9,023K
(-41.29%↓ Y/Y)
Intangible assets, net
$2,441K
Property and equipment,
net
$5K
(-37.50%↓ Y/Y)
Other assets
$1K
(-99.59%↓ Y/Y)
Total assets
$11,470K
(-26.58%↓ Y/Y)
Total liabilities and
stockholders' equity...
$11,470K
(-26.58%↓ Y/Y)
Total liabilities
$9,779K
(32.87%↑ Y/Y)
Total stockholders'
equity (deficit)
$1,691K
(-79.53%↓ Y/Y)
Accumulated deficit
-$650,145K
(-3.43%↓ Y/Y)
Accumulated other
comprehensive (loss) income
-$5K
(-155.56%↓ Y/Y)
Total current
liabilities
$9,735K
(32.41%↑ Y/Y)
Warrant liabilities
$44K
(450.00%↑ Y/Y)
Additional paid-in capital
$651,689K
(2.34%↑ Y/Y)
Common stock, 0.01 par
value, 250,000,000...
$152K
(114.08%↑ Y/Y)
Accounts payable
$6,334K
(33.10%↑ Y/Y)
Accrued expenses and
other liabilities
$3,401K
(31.16%↑ Y/Y)
Back
Back
Balance Sheet
Traws Pharma, Inc. (TRAW)
Traws Pharma, Inc. (TRAW)
source: myfinsight.com